Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Intranasal Testosterone (NatestoTM) for Treatment of Hypogonadism on Maintenance of Spermatogenesis

NCT05381831 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT05381831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05381831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Intranasal Testosterone (NatestoTM) for Treatment of Hypogonadism on Maintenance of Spermatogenesis
Lead sponsor
University of Florida
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2022
Completion date
April 21, 2025
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism, male